Filtration Products was the largest of Repligen Corp’s 6 reported lines in fiscal 2025, at $402.79M — 55% of $738.26M.
| Product and Service | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Filtration Products | $495.93M | — | $341.38M | $372.96M | $402.79M | ||||||||
| Proteins Products | $114.32M | — | $103.46M | $74.43M | $97.44M | ||||||||
| Chromatography Products | $131.68M | — | $126.63M | $122.81M | $153.18M | ||||||||
| Protein Products | — | — | — | — | — | ||||||||
| Process Analytics Products | $53.51M | — | $56.82M | $59.30M | $81.24M | ||||||||
| Product Revenue | — | $17.30M | — | — | — | ||||||||
| Other Products | $5.74M | — | $3.69M | $4.68M | $3.32M | ||||||||
| Other | — | — | — | — | — | ||||||||
| Royalty & Other Revenue | — | — | $383.00K | $261.00K | $296.00K | ||||||||
| Royalty & Other Income | $353.00K | — | — | — | — | ||||||||
| Royalty | — | — | — | — | — | ||||||||
| Total | $801.54M | $17.30M | $632.36M | $634.44M | $738.26M |
In fiscal 2025, which ended December 31, 2025, the 6 revenue lines Repligen Corp reported in this breakdown added up to $738.26M. That was up 16.4% from $634.44M in fiscal 2024. Filtration Products was the largest revenue line, at $402.79M or 54.6% of the total, followed by Chromatography Products ($153.18M, 20.7%) and Proteins Products ($97.44M, 13.2%). Together, the two largest revenue lines made up 75.3% of this total.
Compared with fiscal 2024, Process Analytics Products grew the fastest, rising 37.0% to $81.24M. Every sizeable revenue line reported in both years grew.
Royalty & Other Revenue was first reported as a separate revenue line in fiscal 2023. The table also keeps 5 revenue lines that Repligen Corp no longer reports, so earlier years can still be read on their original basis; use "Show 5 discontinued" beneath the table to see them. This breakdown covers 13 fiscal years between 2014 and 2025, as reported in Repligen Corp's annual filings.
Repligen Corp (RGEN) breaks its revenue down by revenue line. In fiscal 2025, its largest revenue line was Filtration Products, with $402.79M or 54.6% of the total, followed by Chromatography Products at $153.18M (20.7%).
Filtration Products was Repligen Corp's largest revenue line in fiscal 2025, with $402.79M in revenue, 54.6% of the $738.26M reported across its 6 revenue lines.
Of the Repligen Corp revenue lines reported in both fiscal 2024 and fiscal 2025, and making up at least 2% of the total, Process Analytics Products grew the fastest, rising 37.0% from $59.30M to $81.24M.
Every figure is taken from Repligen Corp's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by revenue line covers fiscal 2014 to 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.